First-Line Platinum-Based Chemotherapy with Novel Systemic Agents for Unresectable or Metastatic Thymic Epithelial Tumors: A Systematic Review and Meta-Analysis

Background: Thymic epithelial tumors, including thymomas and thymic carcinomas (TC), are rare thoracic malignancies with poor prognosis in advanced stages. Platinum-based chemotherapy (CT) remains the first-line standard with limited efficacy. Novel systemic therapies, such as immune checkpoint inhi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Gabriela Barbosa e Silva, MD, Lorrany Larisse Costa Rodrigues, BSc, Bianca Gonzaga Freitas, BSc, Leticia Peixoto Gomes, BSc, Mariana Macambira Noronha, BSc, Filipe Luís Vasconcelos Visani, MD
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2026-06-01
Edice:	JTO Clinical and Research Reports
Témata:	Thymic epithelial tumors Thymic carcinoma Thymomas Immunotherapy Antiangiogenic
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2666364326000421
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!